Su Yang Selected Research

Spinocerebellar Ataxia 17

1/2018	Piperine ameliorates SCA17 neuropathology by reducing ER stress.
1/2017	Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
1/2016	Molecular mechanisms underlying Spinocerebellar Ataxia 17 (SCA17) pathogenesis.
1/2014	Age-dependent decrease in chaperone activity impairs MANF expression, leading to Purkinje cell degeneration in inducible SCA17 mice.
7/2011	Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Su Yang Research Topics

Disease

10	Neoplasms (Cancer) 09/2021 - 01/2012
8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 07/2011
5	Stroke (Strokes) 10/2022 - 01/2015
5	Inflammation (Inflammations) 09/2021 - 01/2017
5	Spinocerebellar Ataxia 17 01/2018 - 07/2011
4	Yin Deficiency (Yinxu) 01/2020 - 01/2018
4	Pulmonary Tuberculosis 01/2019 - 01/2017
3	Huntington Disease (Huntington's Disease) 11/2022 - 01/2017
3	Infarction (Infarctions) 10/2022 - 01/2020
3	Ischemic Stroke 10/2022 - 01/2020
3	Esophageal Neoplasms (Esophageal Cancer) 06/2022 - 05/2012
2	Ischemia 10/2022 - 01/2020
2	Thrombosis (Thrombus) 03/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 01/2015
2	Lung Neoplasms (Lung Cancer) 06/2021 - 01/2015
2	Carcinogenesis 01/2021 - 01/2015
2	Hemorrhage 12/2020 - 01/2018
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020 - 07/2011
2	Pathologic Constriction (Stenosis) 04/2018 - 01/2016
2	Ataxia (Dyssynergia) 01/2017 - 01/2012
2	Neoplasm Metastasis (Metastasis) 10/2016 - 05/2012
2	Glioblastoma (Glioblastoma Multiforme) 02/2016 - 01/2012
2	Cardiac Arrhythmias (Arrythmia) 01/2016 - 08/2008
2	Infections 01/2016 - 10/2013
2	Esophageal Squamous Cell Carcinoma 02/2015 - 05/2014
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022
1	Alzheimer Disease (Alzheimer's Disease) 05/2022
1	Carotid Artery Thrombosis 03/2022
1	Cognitive Dysfunction 09/2021
1	Colonic Neoplasms (Colon Cancer) 09/2021
1	Neuralgia (Stump Neuralgia) 03/2021
1	Glioma (Gliomas) 01/2021
1	Hematoma 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Acoustic Neuroma (Acoustic Neurinoma) 12/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Multiple Myeloma 01/2020
1	Multiple Sclerosis 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Bacterial Vaginosis 12/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019
1	Lymphoma (Lymphomas) 01/2019

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2017
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2014
6	polyglutamineIBA 01/2020 - 07/2011
5	Therapeutic UsesIBA 10/2022 - 02/2014
5	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2020 - 07/2011
4	tributyl phosphate (TBP)IBA 01/2020 - 01/2014
4	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2012
3	Indicators and Reagents (Reagents)IBA 09/2021 - 05/2012
3	CytokinesIBA 01/2020 - 01/2002
3	zhibai dihuangIBA 01/2020 - 01/2018
3	InflammasomesIBA 01/2020 - 01/2020
2	IronIBA 01/2021 - 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	Oxygen (Dioxygen)IBA 10/2022
1	roxadustatIBA 10/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 03/2022
1	ferric chlorideIBA 03/2022
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 09/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2021
1	dimethyl itaconateIBA 09/2021
1	cyclopamineIBA 09/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2021
1	ClusterinIBA 06/2021
1	Reverse Transcriptase InhibitorsIBA 03/2021
1	NucleosidesIBA 03/2021
1	Pharmaceutical PreparationsIBA 03/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	relmacabtagene autoleucelIBA 01/2021
1	pyridoxal isonicotinoyl hydrazoneIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	Matrix Metalloproteinases (MMPs)IBA 12/2020
1	Autophagy-Related ProteinsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	NLR ProteinsIBA 01/2020
1	belnacasanIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	laquinimodIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	MelatoninIBA 01/2020
1	Neuraminidase (Sialidase)IBA 12/2019
1	Chimeric Antigen ReceptorsIBA 12/2019
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	InterleukinsIBA 01/2019

Therapy/Procedure

12	Therapeutics 11/2022 - 08/2008
6	Esophagectomy 06/2022 - 05/2014
4	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 05/2014
3	Radiotherapy 06/2021 - 02/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2018
2	Drug Therapy (Chemotherapy) 06/2021 - 01/2017
1	Transplantation 10/2022
1	Neoadjuvant Therapy 06/2022
1	Craniotomy 01/2022
1	Stem Cell Transplantation 11/2020
1	Immunotherapy 12/2019